ADH5 and hypertensive disorder: N6022 and other inhibitors of GSNOR have been shown to decrease inflammation and disease severity in animal models of tobacco smoke induced chronic obstructive pulmonary disease[51], chemically induced colitis[52], acetaminophen induced hepatotoxicity[53], and high salt diet induced hypertension[46].